Clinical Trial Update: Intranasal Remimazolam for Premedication in Pediatric Patient [Phase 4]

View source ↗

Summary

Phase 4 trial update for intranasal remimazolam used as premedication in pediatric patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorder
• Sedative State Disorder

Drugs mentioned

• Remimazolam (remimazolam)

Snippet

Sponsor: Second Affiliated Hospital of Wenzhou Medical University | Conditions: Sedative; Anxiety Disorder | Phase 4 | Status: COMPLETED